Dr. Linda Ma Pak, MD

Dr. Pak practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Pak's NPI, 1427497007, was assigned on June 18, 2013. Dr. Pak graduated from University Of Michigan Medical School in 2013. Dr. Pak's Massachusetts license number on file is 273463.

Dr. Pak's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Pak's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Pak is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Pak to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pak practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Pak's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Pak is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Pak's licenses on file in 4 states: Massachusetts, New York, Texas and Missouri.

Dmand AI lists mastectomy among the conditions Dr. Pak treats.

CMS data shows 16 Medicare services from Dr. Pak across 1 procedure code in 2024, all of them office visits, for 32 Medicare patients. Medicare paid $494 for them. Every service was in an office.

CMS counts 32 Medicare patients who saw Dr. Pak in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pak's median patient age at 65, with 95% women.

In 2022, Dr. Pak wrote 38 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $98 in total drug cost. In 2021, CMS named 26 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Pak for performance year 2024, reported as part of a group. Dr. Pak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of mastectomy by Dr. Pak, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 58 papers to Dr. Pak, published from 2016 to 2023. 2017 was the busiest year, with 10. The most frequent topics are Liver Neoplasms, Breast Neoplasms and Cholangiocarcinoma. Dr. Pak has published most often in Ann Surg Oncol. Dr. Pak's most frequent co-authors are William R. Jarnagin, MD, Vinod P. Balachandran, MD and Ronald P. Dematteo, MD.

CMS Open Payments shows 5 general payments to Dr. Pak from 2 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 62% of the total. AxoGen paid the most, $1,339.

Dr. Pak graduated from University Of Michigan Medical School in 2013.

Dr. Pak is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.